Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Bozdag Turan, Ilkay ^a   Turan, R G ^a   Paranskaya, Lylia ^a   Arsoy, Nicole S ^a   Turan, C H ^a   Akin, Ibrahim ^a   Kische, Stephan ^a   Ortak, Jasmin ^a   Schneider, H ^a   Ludovicy, S ^a   Hermann, Tina ^a   D'Ancona, Giuseppe ^a   Durdu, Serkan ^b   Akar, A R ^b   Ince, Hueseyin ^a   Nienaber, Christoph A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Circulating progenitor cells; Colony forming capacity; Coronary artery disease; Diabetes; Ischemic heart disease; Migration capacity

Indexed keywords

HEMOGLOBIN A1C; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE MARROW DERIVED CIRCULATING PROGENITOR CELL; CARDIOVASCULAR RISK; CELL ASSAY; CELL FUNCTION; CELL MIGRATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; STEM CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELLS; YOUNG ADULT;

EID: 84863504966     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-143     Document Type: Article

References (48)

1. Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 2002, 12:88-96. 10.1016/S1050-1738(01)00152-9, 11852257.
2. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells, new hope for a broken heart. Circulation 2003, 107:3093-3100. 10.1161/01.CIR.0000074242.66719.4A, 12821589.
3. Deschaseaux F, Pontikoglou C, Sensébé L. Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med 2010, 14:103-115. 10.1111/j.1582-4934.2009.00878.x, 19840188.
4. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2010, 13:87-102.
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228. 10.1161/01.RES.85.3.221, 10436164.
6. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia-and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438. 10.1038/7434, 10202935.
7. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoetic progenitor and stem cells. Blood 2001, 97:3354-3360. 10.1182/blood.V97.11.3354, 11369624.
8. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and aniopoietin. Ann NY Acad Sci. 2001, 938:36-47.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600. 10.1056/NEJMoa022287, 12584367.
10. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7. 10.1161/hh1301.093953, 11440984.
11. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786. 10.1161/01.CIR.0000039526.42991.93, 12451003.
12. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, de Kreutzenberg Vigili S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26:2140-2146. 10.1161/01.ATV.0000237750.44469.88, 16857948.
13. Li M, Takeneka H, Asai J, Ibusuki K, Mizukami Y, Maruyama K, Yoon YS, Wecker A, Luedemann C, Eaton E, Silver M, Thorne T, Losordo DW. Endothelial progenitor thrombospondin-1 mediates diabetes induced delay in reendothelialization following arterial injury. Circ Res 2006, 98:697-704. 10.1161/01.RES.0000209948.50943.ea, 16484619.
14. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990, 81:491-497. 10.1161/01.CIR.81.2.491, 2105174.
15. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A, Russell RO, Ryan TJ, Smith SC. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999, 33:1756-1824. 10.1016/S0735-1097(99)00126-6, 10334456.
16. Heeschen C, Lehman R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622. 10.1161/01.CIR.0000124476.32871.E3, 15037527.
17. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
18. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes. N Engl J Med 2005, 353:999-1007. 10.1056/NEJMoa043814, 16148285.
19. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001, 33:1673-1690. 10.1006/jmcc.2001.1419, 11549346.
20. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2(+) AC133(+) endothelial precursor cells. Circ Res 2001, 88:167-174. 10.1161/01.RES.88.2.167, 11157668.
21. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 1976, 73:651-653. 10.1073/pnas.73.2.651, 335969, 1061164.
22. Opden Buijs J, Musters M, Verrips T, Post JA, Braam B, van Riel N. Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 2004, 287:H2651-H2658. 10.1152/ajpheart.00332.2004, 15284068.
23. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967. 10.1126/science.275.5302.964, 9020076.
24. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427. 16255, 10725398.
25. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637. 10.1161/01.CIR.103.5.634, 11156872.
26. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712. 10.1038/nm0603-702, 12778169.
27. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schäfer B, Hossfeld DK, Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000, 95:3106-3112.
28. Gunsilius E, Duba HC, Petzer AL, Kähler CM, Gastl GA. Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res 2001, 88:E1. 10.1161/01.RES.88.1.e1, 11139484.
29. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110:2039-2046. 10.1161/01.CIR.0000143161.01901.BD, 15451799.
30. Nowak G, Karrar A, Holmen C, Nava S, Uzunel M, Hultenby K, Sumitran-Holgersson S. Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 2004, 110:3699-3707. 10.1161/01.CIR.0000143626.16576.51, 15381639.
31. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Böhm M, Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003, 107:3059-3065. 10.1161/01.CIR.0000077911.81151.30, 12810616.
32. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024. 10.1161/01.CIR.0000018166.84319.55, 12081997.
33. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22:1567-1572. 10.1161/01.ATV.0000036417.43987.D8, 12377731.
34. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93:e17-e24. 10.1161/01.RES.0000083812.30141.74, 12829619.
35. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108:457-463. 10.1161/01.CIR.0000082924.75945.48, 12860902.
36. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Eng J Med 2000, 342:626-633.
37. Pilarisetti K, Gupta SK. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1) 1:SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 2001, 25:293-300. 10.1023/A:1012808525370, 11820456.
38. Yamaguchi J, Kussano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328. 10.1161/01.CIR.0000055313.77510.22, 12628955.
39. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, Keren G. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003, 23:e57-e60. 10.1161/01.ATV.0000107029.65274.db, 14615392.
40. Turan RG, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, Turan CH, Rehders TC, Rauchhaus M, Kleinfeldt T, Adolph E, Brehm M, Yokus S, Steiner S, Sahin K, Nienaber CA, Ince H. Improved mobilisation of the CD34+ and CD133+ bone marrow derived circulating progenitor cells by freshly isolated intracoronary bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell and Dev 2011, 20(9):1491-1501.
41. Turan RG, Bozdag-Turan I, Ortak J, Kische S, Akin I, Schneider H, Turan CH, Rehders TC, Rauchhaus M, Kleinfeldt T, Belu C, Brehm M, Yokus S, Steiner S, Sahin K, Nienaber CA, Ince H. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev 2011, 7(3):646-656. 10.1007/s12015-010-9220-8, 3137778, 21188654.
42. Turan RG, Bozdag-Turan I, Turan CH, Ortak J, Akin I, Kische S, Schneider H, Rauchhaus M, Rehders TC, Kleinfeldt T, Belu C, Amen S, Hermann T, Yokus S, Brehm M, Steiner S, Chatterjee T, Sahin K, Nienaber CA, Ince H. Enhanced mobilisation of the bone marrow derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. J Cell Mol Med 2012, 16(4):852-864. 10.1111/j.1582-4934.2011.01358.x, 21707914.
43. Turan RG, Turan CH, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, Kleinfeldt T, Rehders TC, Rauchhaus M, Adolph E, Amen S, Hermann T, Yokus S, Brehm M, Steiner S, Sahin K, Nienaber CA, Ince H. Impaired Mobilization of CD133(+) Bone Marrow-Derived Circulating Progenitor Cells With an Increased Number of Diseased Coronary Arteries in Ischemic Heart Disease Patients With Diabetes. Circ J 2011, 75(11):2635-2641. 10.1253/circj.CJ-10-1284, 21828932.
44. Bozdag-Turan I, Turan RG, Turan CH, Ludovicy S, Akin I, Kische S, Arsoy NS, Schneider H, Ortak J, Rehders T, Hermann T, Paranskaya L, Kohlschein P, Bastian M, Ulus AT, Sahin K, Ince H, Nienaber CA. Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Cardiovasc Diabetol 2011, 10:107. 10.1186/1475-2840-10-107, 3235974, 22118372.
45. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999, 99:2239-2242. 10.1161/01.CIR.99.17.2239, 10226087.
46. Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, Guberski DL, Kern TS, Grant MB. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes J 2007, 56:960-967.
47. Werner C, Kamani CH, Gensch C, Böhm M, Laufs U. The peroxisome proliferator-activated receptor-y agonist pioglitazone increases number and function of endothelial progenitor cells in patients with Coronary Artery Disease and normal glucose tolerance. Diabetes J 2007, 56:2609-2615.
48. Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, Akie TK, Soma T, Taguchi A, Yoshimasa Y. Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients. Diabetes Res Clin Pract 2008, 81:327-330. 10.1016/j.diabres.2008.05.012, 18639363.